SANTA ANA, Calif.--(BUSINESS WIRE)--Advanced Medical Optics, Inc. (AMO) (NYSE:EYE) today announced that it intends to offer, subject to market conditions and other factors, approximately $200 million aggregate principal amount of senior subordinated notes due 2017. The offering will be made only to qualified institutional buyers and non-U.S. foreign investors in accordance with Rule 144A and Regulation S, respectively, under the Securities Act of 1933. The notes will be unsecured senior subordinated obligations of AMO. The interest rate and other terms of the notes will be determined by negotiations between AMO and the initial purchasers of the notes.
